Dolca Thomas
2019 - Principia Biopharma
In 2019, Dolca Thomas earned a total compensation of $2.2M as Chief Medical Officer at Principia Biopharma, a 39% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $224,910 |
|---|---|
| Option Awards | $1,584,798 |
| Salary | $428,400 |
| Other | $375 |
| Total | $2,238,483 |
Thomas received $1.6M in option awards, accounting for 71% of the total pay in 2019.
Thomas also received $224.9K in non-equity incentive plan, $428.4K in salary and $375 in other compensation.
Rankings
In 2019, Dolca Thomas' compensation ranked 5,353rd out of 13,971 executives tracked by ExecPay. In other words, Thomas earned more than 61.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,353 out of 13,971 | 62nd |
Division Manufacturing | 1,998 out of 5,701 | 65th |
Major group Chemicals And Allied Products | 708 out of 2,200 | 68th |
Industry group Drugs | 594 out of 1,886 | 69th |
Industry Pharmaceutical Preparations | 441 out of 1,398 | 69th |
Source: SEC filing on April 24, 2020.
Thomas' colleagues
We found two more compensation records of executives who worked with Dolca Thomas at Principia Biopharma in 2019.